A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer
Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
A Single Blind, Two-Stage Dose Finding Study to Evaluate the Safety, Tolerability and
Efficacy of a Single Liproca® Depot Injection into the Prostate in Patients with Localized
Prostate Cancer,Assigned to Active Surveillance who are at High Risk for Disease Progression
(followed by an Open Label Extension with a Repeat Injection (Optional))